Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma.
Camacho X, Calzada V, Fernandez M, Alonso O, Chammas R, Riva E, Gambini JP, Cabral P. Camacho X, et al. Among authors: riva e. Curr Radiopharm. 2017;10(1):21-28. doi: 10.2174/1874471009666161010155246. Curr Radiopharm. 2017. PMID: 27748184
[177Lu]DOTA-anti-CD20: labeling and pre-clinical studies.
Audicio PF, Castellano G, Tassano MR, Rezzano ME, Fernandez M, Riva E, Robles A, Cabral P, Balter H, Oliver P. Audicio PF, et al. Among authors: riva e. Appl Radiat Isot. 2011 Jul;69(7):924-8. doi: 10.1016/j.apradiso.2011.01.026. Epub 2011 Jan 26. Appl Radiat Isot. 2011. PMID: 21474325
99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents.
Camacho X, Perroni C, Machado CL, de Godoi Carneiro C, de Souza Junqueira M, Faria D, García MF, Fernández M, Oddone N, Benech J, Buchpiguel CA, Cerecetto H, Chammas R, Riva E, Cabral P, Gambini JP. Camacho X, et al. Among authors: riva e. Anticancer Agents Med Chem. 2021;21(14):1883-1893. doi: 10.2174/1871520621999210104181238. Anticancer Agents Med Chem. 2021. PMID: 33397271
Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple).
Riva E, Schütz N, Peña C, Ruiz-Argüelles G, Hopkins CR, Bove V, Villano F, Andino L, Suárez L, Martínez H, Navarro J, López-Vidal H, Da Costa O, Pineda MR, Rubio Y, Ramirez J, Choque J, Fantl D. Riva E, et al. Ann Hematol. 2020 May;99(5):1025-1030. doi: 10.1007/s00277-020-03983-x. Epub 2020 Mar 10. Ann Hematol. 2020. PMID: 32157420 Clinical Trial.
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
Malpica L, Enriquez DJ, Castro DA, Peña C, Idrobo H, Fiad L, Prates M, Otero V, Biglione M, Altamirano M, Sandival-Ampuero G, Aviles-Perez U, Meza K, Aguirre-Martinez L, Cristaldo N, Maradei JL, Guanchiale L, Soto P, Viñuela JL, Cabrera ME, Paredes SR, Riva E, Di Stefano M, Noboa A, Choque JA, Candelaria M, Von Glasenapp A, Valvert F, Torres-Viera MA, Castillo JJ, Ramos JC, Villela L, Beltran BE. Malpica L, et al. Among authors: riva e. JCO Glob Oncol. 2021 Jul;7:1151-1166. doi: 10.1200/GO.21.00084. JCO Glob Oncol. 2021. PMID: 34270330 Free PMC article.
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
Riva E, Duarte PJ, Valcárcel B, Remaggi G, Murrieta I, Corzo A, Del Carpio D, Peña C, Vásquez J, Bove V, Teixeira L, Fleury-Perini G, Yantorno S, Samánez C, Lopresti S, Altamirano M, Villela L, Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Montaño E, Verri V, Zamora Pérez E, Pérez Jacobo F, Idrobo H, Martínez-Cordero H, Beltran BE, Ramírez J, Castillo JJ, Malpica Castillo LE. Riva E, et al. JCO Glob Oncol. 2022 Aug;8:e2100380. doi: 10.1200/GO.21.00380. JCO Glob Oncol. 2022. PMID: 35939775 Free PMC article.
637 results